Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MitrAssist Medical Ltd.

“Valve-in-valve” approach to mitral regurgitation

This article was originally published in Start Up

Executive Summary

Just as people improve their vision by wearing glasses or contact lenses instead of repairing or replacing their eyes, a mitral valve prosthesis from Israeli-based MitrAssist Medical Ltd. neither repairs nor replaces damaged mitral valves in the heart, but rather it augments and enhances native valve function. The company’s implant is placed on top of the native valve and anchored securely. This “valve-in-valve” approach is designed to prevent leakage and restore normal blood flow.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT037820

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel